Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Cancer Research
|
August 17, 2019
Editor's Note: <i>Listeria monocytogenes</i> Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 Signaling
Bo Huang, Jie Zhao, Shiqian Shen, et al.
Gut
|
October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis
William J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Cancer Research
|
May 8, 2007
Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling
Bo Huang, Jie Zhao, Shiqian Shen, et al.
Gastroenterology
|
August 2, 2003
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial
William J Sandborn, Daniel H Present, Kim L Isaacs, et al.
BMC Medical Genetics
|
May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
Inga Peter, Adele A Mitchell, Laurie Ozelius, et al.
Gastroenterology
|
May 31, 2012
A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans
Gerold Bongers, Luciana R Muniz, Michelle E Pacer, et al.
Gastroenterology
|
June 9, 2009
Expression of the chemokine binding protein M3 promotes marked changes in the accumulation of specific leukocytes subsets within the intestine
Limin Shang, Nanthakumar Thirunarayanan, Abel Viejo-Borbolla, et al.
The American Journal of Gastroenterology
|
October 11, 2008
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial
James F Marion, Jerome D Waye, Daniel H Present, et al.
Gastroenterology & Hepatology
|
October 1, 2011
A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency
Ali Keshavarzian, Lloyd Mayer, Bruce Salzberg, et al.
The Journal of Allergy and Clinical Immunology
|
January 1, 2013
The natural history of milk allergy in an observational cohort
Robert A Wood, Scott H Sicherer, Brian P Vickery, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Cancer Research
|
August 17, 2019
Editor's Note: <i>Listeria monocytogenes</i> Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 Signaling
Bo Huang, Jie Zhao, Shiqian Shen, et al.
Gut
|
October 16, 2010
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis
William J Sandborn, Jean Frederic Colombel, Matthew Frankel, et al.
Cancer Research
|
May 8, 2007
Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling
Bo Huang, Jie Zhao, Shiqian Shen, et al.
Gastroenterology
|
August 2, 2003
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial
William J Sandborn, Daniel H Present, Kim L Isaacs, et al.
BMC Medical Genetics
|
May 10, 2011
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study
Inga Peter, Adele A Mitchell, Laurie Ozelius, et al.
Gastroenterology
|
May 31, 2012
A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans
Gerold Bongers, Luciana R Muniz, Michelle E Pacer, et al.
Gastroenterology
|
June 9, 2009
Expression of the chemokine binding protein M3 promotes marked changes in the accumulation of specific leukocytes subsets within the intestine
Limin Shang, Nanthakumar Thirunarayanan, Abel Viejo-Borbolla, et al.
The American Journal of Gastroenterology
|
October 11, 2008
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial
James F Marion, Jerome D Waye, Daniel H Present, et al.
Gastroenterology & Hepatology
|
October 1, 2011
A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency
Ali Keshavarzian, Lloyd Mayer, Bruce Salzberg, et al.
The Journal of Allergy and Clinical Immunology
|
January 1, 2013
The natural history of milk allergy in an observational cohort
Robert A Wood, Scott H Sicherer, Brian P Vickery, et al.
Page
of 13